DexCom, Inc. is a medical device company that specializes in continuous glucose monitoring (CGM) systems for individuals with diabetes and healthcare providers. Its main products include the DexCom G6 (approximately 40% of revenue), Dexcom G7, Dexcom ONE, Dexcom Share, and the Dexcom Real-Time API. Revenue primarily comes from sales of these CGM systems and related services. Factors supporting the company's endurance include the growing prevalence of diabetes and increasing demand for real-time health monitoring. However, competition from other medical device manufacturers and potential regulatory challenges could limit its market position.
—
DexCom, Inc. is a medical device company that specializes in continuous glucose monitoring (CGM) systems for individuals with diabetes and healthcare providers. Its main products include the DexCom G6 (approximately 40% of revenue), Dexcom G7, Dexcom ONE, Dexcom Share, and the Dexcom Real-Time API. Revenue primarily comes from sales of these CGM systems and related services. Factors supporting the company's endurance include the growing prevalence of diabetes and increasing demand for real-time health monitoring. However, competition from other medical device manufacturers and potential regulatory challenges could limit its market position.
—
Daily adjusted close
DexCom, Inc. is a medical device company that specializes in continuous glucose monitoring (CGM) systems for individuals with diabetes and healthcare providers. Its main products include the DexCom G6 (approximately 40% of revenue), Dexcom G7, Dexcom ONE, Dexcom Share, and the Dexcom Real-Time API. Revenue primarily comes from sales of these CGM systems and related services. Factors supporting the company's endurance include the growing prevalence of diabetes and increasing demand for real-time health monitoring. However, competition from other medical device manufacturers and potential regulatory challenges could limit its market position.